SOBRsafe, a technology company developing advanced alcohol detection solutions, has announced two significant leadership appointments to support its strategic growth and technological innovation. Kris Pederson, a seasoned corporate director with extensive experience at prominent firms including EY, IBM, and PwC, will join the Board of Directors effective May 1, 2025, and will chair the Nominating and Corporate Governance Committee. Complementing Pederson's governance expertise, the company has also named Dr. Benjamin Sanchez as a Scientific Advisor. His appointment in February aims to bolster the company's efforts in securing federal funding and establishing clinical research partnerships.
These strategic additions come at a critical time, as alcohol misuse remains a significant public health challenge. Ranked as the fourth leading cause of preventable death in the United States and seventh globally, the issue underscores the importance of innovative detection and prevention technologies. SOBRsafe's proprietary technology offers a novel approach to alcohol detection through advanced transdermal sensing. Unlike traditional methods requiring breath, blood, or urine samples, the company's platform can instantaneously detect and report alcohol presence through touch-based technology.
The company's solution, which includes point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure), represents a potentially transformative approach to addressing alcohol-related risks in various sectors, including behavioral health, judicial systems, and consumer markets. Pederson's extensive background in corporate leadership and governance, combined with Dr. Sanchez's scientific expertise, positions SOBRsafe to enhance its technological capabilities and strategic direction. These appointments reflect the company's commitment to developing innovative solutions for alcohol misuse prevention and monitoring.
